Mucormycosis

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

07-11-2019

Dear valued colleagues,

The Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium was released on November 4, 2019.

We have released a new video “Mucormycosis – One World – One Guideline” on our “ID in Motion” YouTube channel.

This is the first world-wide guideline intending to diagnose this devastating disease earlier, and to lead to more rapid treatment initiation.
74 experts from 33 countries developed this guidance document. Upon today‘s publication in Lancet Infectious Diseases, scientific societies from 53 countries endorse the guideline.

Here is a link to the publishes article on The Lancet website: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30312-3/fulltext.
Article citation:
Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet Infectious Diseases 2019.

 Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

  TLID 2019 Suppl Mat Global guideline for the diagnosis and management of mucormycosis – an initiative of the ECMM in cooperation with theMSG ERC